Literature DB >> 11897213

Peak early diastolic velocity rather than pressure half-time is the best index of mechanical prosthetic mitral valve function.

Valerian Fernandes1, Leopoldo Olmos, Sherif F Nagueh, Miguel A Quiñones, William A Zoghbi.   

Abstract

Reliable screening of mechanical prosthetic mitral valve (PMV) dysfunction by transthoracic echocardiography (TTE) is mandatory because transesophageal echocardiography (TEE) cannot be routinely used. However, acoustic shadowing seriously hampers detection of PMV dysfunction with TTE, particularly regurgitation. To identify TTE indexes that can detect PMV dysfunction (regurgitation or obstruction), 134 patients (age 60 +/- 12 years, 64 men) with PMV who underwent TTE and TEE within 3 +/- 5 days were assessed. There were 73 normal and 61 dysfunctional valves (40 regurgitant, 21 obstructive). By multivariate analysis, peak E velocity was the best predictor of a dysfunctional valve. Both peak E velocity (E > or =1.9 m/s; sensitivity 92%, specificity 78%) and the ratio of velocity-time integrals of flow through the prosthesis to that of the left ventricular outflow (VTI(pmv/)VTI(lvo) > or =2.2; sensitivity 91%, specificity 74%) were successful in detecting PMV dysfunction. Although pressure half-time (PHT) readily identified PMV obstruction, it did not detect regurgitation. Logistic models including peak E velocity and VTI(pmv)/VTI(lvo) or PHT were equally successful in detecting PMV dysfunction. However, all 3 variables were needed to best distinguish among normal, obstructed, and regurgitant valves. A peak E velocity > or =1.9 m/s and VTI(pmv)/VTI(lvo) ratio > or =2.2 predicted valve regurgitation in 83% of valves when PHT was < 130 ms, and valve stenosis in 95% when PHT was >130 ms. Importantly, a peak E velocity < 1.9 m/s, VTI(pmv)/VTI(lvo) ratio < 2.2, and a PHT < 130 ms had a predictive accuracy for a normal valve of 98%. Thus, TTE Doppler indexes can be used as screening parameters of PMV dysfunction and help select patients for further diagnostic evaluation with TEE.

Entities:  

Mesh:

Year:  2002        PMID: 11897213     DOI: 10.1016/s0002-9149(01)02343-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations.

Authors:  Raymond Roudaut; Karim Serri; Stephane Lafitte
Journal:  Heart       Date:  2007-01       Impact factor: 5.994

2.  Echocardiographic assessment of prosthetic valves.

Authors:  Kazuaki Tanabe
Journal:  J Echocardiogr       Date:  2015-08-19

3.  Identification and quantification of prosthetic mitral regurgitation by flow convergence method using transthoracic approach.

Authors:  Stephane Arques; Caroline Leonnet; Emmanuel Roux; Jean-François Avierinos
Journal:  Cardiovasc Ultrasound       Date:  2009-02-12       Impact factor: 2.062

Review 4.  Mechanical valve obstruction: Review of diagnostic and treatment strategies.

Authors:  Jason Salamon; Jerson Munoz-Mendoza; Jared J Liebelt; Cynthia C Taub
Journal:  World J Cardiol       Date:  2015-12-26

5.  [Imaging following valve replacement].

Authors:  D Dabir; E Arroyo-Ucar; E A Ucar; E Nagel
Journal:  Radiologe       Date:  2013-10       Impact factor: 0.635

Review 6.  Percutaneous treatment of patients with heart diseases: selection, guidance and follow-up. A review.

Authors:  Carla Contaldi; Maria-Angela Losi; Antonio Rapacciuolo; Maria Prastaro; Raffaella Lombardi; Valentina Parisi; Lucia S Parrella; Carlo Di Nardo; Alessandra Giamundo; Roberto Puglia; Giovanni Esposito; Federico Piscione; Sandro Betocchi
Journal:  Cardiovasc Ultrasound       Date:  2012-03-27       Impact factor: 2.062

Review 7.  Echocardiographic Assessment of Heart Valve Prostheses.

Authors:  Chiara Sordelli; Sergio Severino; Luigi Ascione; Pasquale Coppolino; Pio Caso
Journal:  J Cardiovasc Echogr       Date:  2014 Oct-Dec

8.  Adverse Hemodynamic Conditions Associated with Mechanical Heart Valve Leaflet Immobility.

Authors:  Fardin Khalili; Peshala P T Gamage; Richard H Sandler; Hansen A Mansy
Journal:  Bioengineering (Basel)       Date:  2018-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.